Latest:
Direct Partnership With Patients May Accelerate Cancer Research and Precision Oncology
During the past several decades, cancer research has produced revolutionary discoveries leading to dramatic results for many patients.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Giuseppe Lombardi, MD, PhD
Giuseppe Lombardi, MD, PhD is the head of the Neuro-Oncology Unit at Veneto Institute of Oncology IOV-IRCCS in Padua, Italy.
Latest:
Dr Lombardi on Phase 1 Data With Regorafenib Plus Temozolomide and CRT for Newly Diagnosed Glioblastoma
Giuseppe Lombardi, MD, PhD, discusses data with regorafenib plus temozolomide and radiation in newly diagnosed, MGMT-methylated, IDH-wild-type glioblastoma.
Hyun-Woong Cho, MD, PhD
Hyun-Woong Cho, MD, PhD, is part of the Department of Obstetrics and Gynecology at Korea University College of Medicine
Latest:
Dr Cho on the Investigation of Niraparib/Bevacizumab in Platinum-Sensitive, Recurrent Ovarian Cancer
Hyun Woong Cho, MD, PhD, explains the rationale for assessing niraparib/bevacizumab in platinum-sensitive, recurrent ovarian cancer.
Yufei Wang, PhD
Yufei Wang, PhD, is an instructor in medicine, immunology and virology at Dana-Farber Cancer Institute in Boston, Massachusetts
Latest:
Dr Wang on Key Findings From a Study of the Tumor Microenvironment in ccRCC
Yufei Wang, PhD, discusses how the metastasis of ccRCC could rewire the tumor microenvironment and lead to increased immunosuppression and fibrosis.
Lisa Langenderfer
Latest:
Physicians Must Become Advocates to Play a Role in Community Oncology’s Future
Although some community oncologists may think they can do little to abate the reimbursement reform forces that are affecting their practices, there are actions they can, and should, take to influence the success of their value-based care journey that may not be part of the fundamentals of their current practice.
Loyda E. Braithwaite, NP, University of Wisconsin Carbone Cancer Center
Latest:
Test for Summarization
Kathleen N. Moore, MD, MS, discusses the challenges with utilizing immune-targeted therapy for ovarian cancer, expands on the impact of the tumor microenvironment on the effectiveness of immune checkpoint inhibitors, and details ongoing research with different treatment approaches in ovarian cancer.